Related references
Note: Only part of the references are listed.Molecular subtypes of pancreatic cancer
Eric A. Collisson et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts
Ela Elyada et al.
CANCER DISCOVERY (2019)
The Paradoxical Web of Pancreatic Cancer Tumor Microenvironment
Kelly J. Lafaro et al.
AMERICAN JOURNAL OF PATHOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma
Giulia Biffi et al.
CANCER DISCOVERY (2019)
Personalized RNA Medicine for Pancreatic Cancer
Maud-Emmanuelle Gilles et al.
CLINICAL CANCER RESEARCH (2018)
Ruxolitinib plus capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies
Herbert Hurwitz et al.
INVESTIGATIONAL NEW DRUGS (2018)
miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy
Jiajia Xi et al.
ONCOGENE (2018)
Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer
Lulin Zhang et al.
ONCOLOGY RESEARCH (2018)
A Phase Ib study of ruxolitinib plus gemcitabine ± nab-paclitaxel in patients with advanced solid tumors
Todd M. Bauer et al.
ONCOTARGETS AND THERAPY (2018)
The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
Le Ren et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2018)
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Daniel Ohlund et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
MiR-21 is required for anti-tumor immune response in mice: an implication for its bi-directional roles
W. He et al.
ONCOGENE (2017)
miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice (vol 8, e2748, 2017)
Pedro M. Rodrigues et al.
CELL DEATH & DISEASE (2017)
Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm
Krushna C. Patra et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2017)
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
Andrew J. Aguirre et al.
CANCER CELL (2017)
Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS
Wanglong Qiu et al.
GASTROENTEROLOGY (2016)
MicroRNA-21 promotes TGF-β1-induced epithelial-mesenchymal transition in gastric cancer through up-regulating PTEN expression
Chang Li et al.
ONCOTARGET (2016)
TGF-β1 promotes scar fibroblasts proliferation and transdifferentiation via up-regulating MicroRNA-21
Ying Liu et al.
SCIENTIFIC REPORTS (2016)
Pancreatic cancer
Jorg Kleeff et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed
Herbert I. Hurwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer
Daniel V. T. Catenacci et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
Richard A. Moffitt et al.
NATURE GENETICS (2015)
The oncogenic microRNA miR-21 promotes regulated necrosis in mice
Xiaodong Ma et al.
NATURE COMMUNICATIONS (2015)
Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways
Ivan G. Gomez et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Stromal Expression of miR-21 Identifies High-Risk Group in Triple-Negative Breast Cancer
Todd A. MacKenzie et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
Berna C. Oezdemir et al.
CANCER CELL (2014)
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Andrew D. Rhim et al.
CANCER CELL (2014)
Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy
Mara H. Sherman et al.
CELL (2014)
Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
Edward J. Kim et al.
CLINICAL CANCER RESEARCH (2014)
Stromal MicroRNA-21 Levels Predict Response to 5-Fluorouracil in Patients With Pancreatic Cancer
Timothy R. Donahue et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Stromal response to Hedgehog signaling restrains pancreatic cancer progression
John J. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Interaction of the oncogenic miR-21 microRNA and the p53 tumor suppressor pathway
Xiaodong Ma et al.
CARCINOGENESIS (2013)
Genetically engineered mouse models of pancreatic adenocarcinoma
Carmen Guerra et al.
MOLECULAR ONCOLOGY (2013)
MicroRNA-21 Knockout Improve the Survival Rate in DSS Induced Fatal Colitis through Protecting against Inflammation and Tissue Injury
Chenzhang Shi et al.
PLOS ONE (2013)
MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis
Brian E. Kadera et al.
PLOS ONE (2013)
Ovarian cancer progression is controlled by phenotypic changes in dendritic cells
Uciane K. Scarlett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways
B. Nelson Chau et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFβ in pancreatic cancer cells
Lorenzo F. Sempere et al.
CANCER BIOLOGY & THERAPY (2011)
Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis
Xiaodong Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
Mark E. Hatley et al.
CANCER CELL (2010)
Fluorescence-Based Codetection with Protein Markers Reveals Distinct Cellular Compartments for Altered MicroRNA Expression in Solid Tumors
Lorenzo F. Sempere et al.
CLINICAL CANCER RESEARCH (2010)
MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions
Mael Chalret du Rieu et al.
CLINICAL CHEMISTRY (2010)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Inactivation of TIF1γ Cooperates with KrasG12D to Induce Cystic Tumors of the Pancreas
David F. Vincent et al.
PLOS GENETICS (2009)
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer
Nabeel Bardeesy et al.
GENES & DEVELOPMENT (2006)
Both p16Ink4a and the p19Arf-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse
N Bardeesy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Share Paper
